Earlier this week in an opinion piece for the New York Times filmmaker, Angelina Jolie Pitt describes her decision to have her ovaries and fallopian tubes removed. The surgery comes just two years after her choice to have a double mastectomy. Genetic tests had confirmed she carried a mutation in the BRCA gene which put her at greater risk for breast and ovarian cancer. Many doctors say her decision was a good one, but it highlights the kinds of challenges genetic test results can present: Please join us to discuss BRCA test results and efforts to stop breast and ovarian cancers before they start.


  • Mary-Claire King Professor of medicine and genome sciences, University of Washington.
  • Beth Peshkin Senior genetics counselor, Lombardi Comprehensive Cancer Center and professor of oncology,Georgetown University Medical Center.
  • Dr Amanda Nickles Fader Director, Kelly Gynecologic Oncology Service, associate professor of gynecology and obstetrics, Johns Hopkins Medicine.

Topics + Tags


comments powered by Disqus
Most Recent Shows

The Case For The Presidential Debate

Tuesday, Aug 11 2020Nothing about the 2020 presidential campaign is typical and the debates are no different. Diane talks with Janet Brown, executive director of the Commission on Presidential Debates, about how they are planning in the middle of a pandemic.

Could This Be The End Of The NRA?

Friday, Aug 07 2020In a lawsuit filed this week, New York Attorney General Letitia James said a months long investigation into the National Rifle Association found extensive "fraud and abuse" and she's calling for the powerful gun rights organization to be dissolved. Diane talks with Adam Winkler, professor of law at UCLA, about the lawsuit and what comes next.